Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduced hexokinase II impairs muscle function 2 wk after ischemia-reperfusion through increased cell necrosis and fibrosis.
Smeele KM, Eerbeek O, Schaart G, Koeman A, Bezemer R, Nelson JK, Ince C, Nederlof R, Boek M, Laakso M, de Haan A, Drost MR, Hollmann MW, Zuurbier CJ. Smeele KM, et al. Among authors: zuurbier cj. J Appl Physiol (1985). 2012 Aug 15;113(4):608-18. doi: 10.1152/japplphysiol.01494.2011. Epub 2012 Jun 21. J Appl Physiol (1985). 2012. PMID: 22723631 Free article.
Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol.
Xiao Y, Phelp P, Wang Q, Bakker D, Nederlof R, Hollmann MW, Zuurbier CJ. Xiao Y, et al. Among authors: zuurbier cj. Front Cardiovasc Med. 2021 Aug 30;8:712478. doi: 10.3389/fcvm.2021.712478. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34527711 Free PMC article.
Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart.
Nederlof R, Gürel-Gurevin E, Eerbeek O, Xie C, Deijs GS, Konkel M, Hu J, Weber NC, Schumacher CA, Baartscheer A, Mik EG, Hollmann MW, Akar FG, Zuurbier CJ. Nederlof R, et al. Among authors: zuurbier cj. J Physiol Biochem. 2016 Aug;73(3):323-333. doi: 10.1007/s13105-017-0555-3. Epub 2017 Mar 3. J Physiol Biochem. 2016. PMID: 28258543 Free PMC article.
Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells.
Uthman L, Homayr A, Juni RP, Spin EL, Kerindongo R, Boomsma M, Hollmann MW, Preckel B, Koolwijk P, van Hinsbergh VWM, Zuurbier CJ, Albrecht M, Weber NC. Uthman L, et al. Among authors: zuurbier cj. Cell Physiol Biochem. 2019;53(5):865-886. doi: 10.33594/000000178. Cell Physiol Biochem. 2019. PMID: 31724838 Free article.
Empagliflozin Decreases Lactate Generation in an NHE-1 Dependent Fashion and Increases α-Ketoglutarate Synthesis From Palmitate in Type II Diabetic Mouse Hearts.
Zhang H, Uthman L, Bakker D, Sari S, Chen S, Hollmann MW, Coronel R, Weber NC, Houten SM, van Weeghel M, Zuurbier CJ. Zhang H, et al. Among authors: zuurbier cj. Front Cardiovasc Med. 2020 Dec 4;7:592233. doi: 10.3389/fcvm.2020.592233. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33344518 Free PMC article.
121 results